CN101541829A - 来自丝光绿蝇的胰凝乳蛋白酶及其在治疗伤口中的用途 - Google Patents

来自丝光绿蝇的胰凝乳蛋白酶及其在治疗伤口中的用途 Download PDF

Info

Publication number
CN101541829A
CN101541829A CNA2007800285593A CN200780028559A CN101541829A CN 101541829 A CN101541829 A CN 101541829A CN A2007800285593 A CNA2007800285593 A CN A2007800285593A CN 200780028559 A CN200780028559 A CN 200780028559A CN 101541829 A CN101541829 A CN 101541829A
Authority
CN
China
Prior art keywords
quimotrase
wound
cell
purposes
migration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800285593A
Other languages
English (en)
Chinese (zh)
Inventor
D·I·普理查
A·J·霍罗宾
A·布朗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UK Secretary of State for Defence
Original Assignee
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UK Secretary of State for Defence filed Critical UK Secretary of State for Defence
Publication of CN101541829A publication Critical patent/CN101541829A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CNA2007800285593A 2006-05-31 2007-05-31 来自丝光绿蝇的胰凝乳蛋白酶及其在治疗伤口中的用途 Pending CN101541829A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0610697A GB0610697D0 (en) 2006-05-31 2006-05-31 Larval enzyme
GB0610697.5 2006-05-31
US60/837,982 2006-08-15

Publications (1)

Publication Number Publication Date
CN101541829A true CN101541829A (zh) 2009-09-23

Family

ID=36694642

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800285593A Pending CN101541829A (zh) 2006-05-31 2007-05-31 来自丝光绿蝇的胰凝乳蛋白酶及其在治疗伤口中的用途

Country Status (3)

Country Link
JP (1) JP4811885B2 (ja)
CN (1) CN101541829A (ja)
GB (1) GB0610697D0 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675409A (zh) * 2012-04-25 2012-09-19 大连医科大学附属第一医院 可保持五谷虫分泌排泄物活性的收集液
CN111233973A (zh) * 2020-02-21 2020-06-05 重庆医药高等专科学校 一种精氨酸衍生物Pro-Phe-Arg-AMC的合成方法及用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9925005D0 (en) * 1999-10-22 1999-12-22 Univ Nottingham The treatment of wounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675409A (zh) * 2012-04-25 2012-09-19 大连医科大学附属第一医院 可保持五谷虫分泌排泄物活性的收集液
CN111233973A (zh) * 2020-02-21 2020-06-05 重庆医药高等专科学校 一种精氨酸衍生物Pro-Phe-Arg-AMC的合成方法及用途

Also Published As

Publication number Publication date
GB0610697D0 (en) 2006-07-12
JP2009538611A (ja) 2009-11-12
JP4811885B2 (ja) 2011-11-09

Similar Documents

Publication Publication Date Title
Swenson et al. Snake venom fibrin (ogen) olytic enzymes
Horobin et al. Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions
Horobin et al. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin‐coated surface
Glasser et al. Mechanisms of lung fibrosis resolution
Mukherjee et al. Biochemical and pharmacological properties of a new thrombin-like serine protease (Russelobin) from the venom of Russell's Viper (Daboia russelii russelii) and assessment of its therapeutic potential
KR101517626B1 (ko) 감염에 대항하는 후보물질
Naito et al. Smooth muscle cell outgrowth stimulated by fibrin degradation products: the potential role of fibrin fragment E in restenosis and atherogenesis
Bernstein et al. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation
US8728512B2 (en) Treatment and composition for wound healing
Shi et al. Degradation of human collagen isoforms by Clostridium collagenase and the effects of degradation products on cell migration
US20070066538A1 (en) Treatment of wounds
Basilico et al. Dextran-shelled oxygen-loaded nanodroplets reestablish a normoxia-like pro-angiogenic phenotype and behavior in hypoxic human dermal microvascular endothelium
ES2386766T3 (es) Proteasa para el acondicionamiento de heridas y el cuidado de la piel
CN1643140A (zh) 生长因子和蛋白酶的组合
Avila‑Rodríguez et al. Practical context of enzymatic treatment for wound healing: A secreted protease approach
Girón et al. Functional characterization of fibrinolytic metalloproteinases (colombienases) isolated from Bothrops colombiensis venom
Swenson et al. α-Fibrinogenases
Matsumoto et al. Proteolytic activation of corneal matrix metalloproteinase by Pseudomonas aeruginosa elastase
AU2007266775B2 (en) Chymotrypsin from Lucilia sericata larvae and its use for the treatment of wounds
CN101541829A (zh) 来自丝光绿蝇的胰凝乳蛋白酶及其在治疗伤口中的用途
CN101365472B (zh) 基于lopap的药物组合物及其应用
AU2003213863B2 (en) Prothrombin activating protein
US20050053597A1 (en) Composition and method for treatment of wounds
RU2346983C1 (ru) Способ получения активатора плазминогена
US20190060506A1 (en) Elafin Incorporated Biomaterials for the Treatment of Chronic Tissue Ulcers

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20090923